Glyphosate Rift Turns FDA Nomination Into Test of MAHA’s Pesticide Agenda

The Washington Post reports that prominent MAHA activists are opposing FDA nominee Heidi Overton over her perceived role in a Trump order supporting domestic glyphosate production. The White House says she joined the process late and sought MAHA-aligned changes; her Senate confirmation was already uncertain.

Under the Headline

FDA does not evaluate pesticide safety, making Overton’s nomination a proxy fight over whether MAHA will confront agricultural chemical interests. The dispute shows glyphosate becoming a political loyalty test—and exposes the gap between the coalition’s health rhetoric and the administration’s production policy.